- Low-Dose Prasugrel in Treatment of Cerebral Aneurysms
-
Kang HS
- KMID: 2424062
- Neurointervention.
- 2018 Sep;13(2):128-128.
- doi: 10.5469/neuroint.2018.01092
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Low-dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms: Follow-up of over 6 Months
-
Lee D, Song Y, Shin JH, Suh DC
- KMID: 2446785
- Neurointervention.
- 2019 Mar;14(1):68-70.
- doi: 10.5469/neuroint.2019.00052
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Prasugrel-Induced Hypersensitivity Skin Reaction
-
Kim SH, Park SD, Baek YS, Lee SY, Shin SH, Woo SI, Kim DH, Kwan J
- KMID: 2223877
- Korean Circ J.
- 2014 Sep;44(5):355-357.
- doi: 10.4070/kcj.2014.44.5.355
We report a case of hypersensitivity skin reaction to prasugrel. The patient exhibited a generalized skin rash after treatment with prasugrel, which was resolved after discontinuation of prasugrel and substitution... -
- CITED
-
- Close
- SHARE
-
- Close
- An Intra-procedural Stent Thrombosis in a Prasugrel Resistant Patient Treated with Ticagrelor
-
Park JH, Hur SH, Cho YK, Park HS, Yoon HJ, Lee SH, Kim HS, Nam CW, Han SW
- KMID: 2307742
- Keimyung Med J.
- 2016 Jun;35(1):18-24.
- doi: 10.0000/kmj.2016.35.1.18
Stent thromboses due to multifactorial causes including hypercoagulable conditions and high on treatment platelet reactivity (HTPR), which means a low response to anti-platelet therapy, especially clopidogrel. Prasugrel is a third... -
- CITED
-
- Close
- SHARE
-
- Close
- Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms
-
Lee D, Song Y, Han M, Park D, Suh DC
- KMID: 2424061
- Neurointervention.
- 2018 Sep;13(2):124-127.
- doi: 10.5469/neuroint.2018.01088
Thromboembolism is one of the major complications of stent assisted coiling in treatment of cerebral aneurysm. Clopidogrel resistance is so common and prasugrel is more effective in its rapid and... -
- CITED
-
- Close
- SHARE
-
- Close
- Lower Loading Dose of Prasugrel Compared with Conventional Loading Doses of Clopidogrel and Prasugrel in Korean Patients Undergoing Elective Coronary Angiography: A Randomized Controlled Study Evaluating Pharmacodynamic Efficacy
-
Lee DH, Kim MH, Guo LZ, Park MK, Yi SJ
- KMID: 2223854
- Korean Circ J.
- 2014 Nov;44(6):386-393.
- doi: 10.4070/kcj.2014.44.6.386
BACKGROUND AND OBJECTIVES: Although prasugrel allows for rapid and potent platelet inhibition, the efficacy and safety of lower doses of prasugrel for patients of East Asian ethnicity has not yet... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Prasugrel Rescue Therapy in Clopidogrel Resistant Patients Who Had Recurrent Stent Thrombosis of Drug-Eluting-Stent: The Role of Prasugrel in Clopidogrel Nonresponders
-
Lee SH, Kim BK, Oh J, Park JS, Lee DJ, Lee HC, Kim JH, Hong MK
- KMID: 2224933
- Korean Circ J.
- 2013 May;43(5):343-346.
- doi: 10.4070/kcj.2013.43.5.343
Stent thrombosis is a very serious problem after drug-eluting stent (DES) implantation even though its incidence is about or less than 1%. As the clopidogrel resistance is expected to play... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral antiplatelet agent hypersensitivity and cross-reactivity managed by successful desensitisation
-
Chin N, Rangamuwa , Mariasoosai R, Carnes J, Thien F
- KMID: 2397068
- Asia Pac Allergy.
- 2015 Jan;5(1):51-54.
- doi: 10.5415/apallergy.2015.5.1.51
Oral platelet aggregation inhibitors are widely used for the treatment and prevention of cardiovascular diseases, including coronary stent thrombosis. Premature discontinuation following percutaneous coronary intervention would pose a grave risk... -
- CITED
-
- Close
- SHARE
-
- Close
- De-Escalation of P2Yâ‚â‚‚ Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention
-
Kupka D, Sibbing D
- KMID: 2420639
- Korean Circ J.
- 2018 Oct;48(10):863-872.
- doi: 10.4070/kcj.2018.0255
Dual antiplatelet therapy (DAPT) — a combination of a P2Yâ‚â‚‚ receptor inhibitor and aspirin — has revolutionized antithrombotic treatment. Potent P2Yâ‚â‚‚ inhibitors such as prasugrel and ticagrelor exhibit a strong... -
- CITED
-
- Close
- SHARE
-
- Close
- Randomized Comparison of the Platelet Inhibitory Efficacy between Low Dose Prasugrel and Standard Dose Clopidogrel in Patients Who Underwent Percutaneous Coronary Intervention
-
Jin HY, Yang TH, Choi KN, Seo JS, Jang JS, Kim DK, Kim DS
- KMID: 2223896
- Korean Circ J.
- 2014 Mar;44(2):82-88.
- doi: 10.4070/kcj.2014.44.2.82
BACKGROUND AND OBJECTIVES: Increased bleeding rates with standard dose prasugrel have led to increased questions about the effectiveness and safety of the lower maintenance dose. We compared platelet inhibitory efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- New Oral Antiplatelet Agents
-
Kang MK, Chang K
- KMID: 2267821
- Korean J Med.
- 2013 Jul;85(1):10-14.
Antiplatelet agents play an essential role in the treatment of acute coronary syndrome (ACS). Aspirin and thienopyridines comprise the major classes of antiplatelet therapies demonstrated to be of benefit in... -
- CITED
-
- Close
- SHARE
-
- Close
- A pharmacodynamic study of the optimal P2Y12 inhibitor regimen for East Asian patients with acute coronary syndrome
-
Lee JH, Ahn SG, Park B, Park SW, Kang YS, Lee JW, Youn YJ, Ahn MS, Kim JY, Yoo BS, Lee SH, Yoon J
- KMID: 2381560
- Korean J Intern Med.
- 2015 Sep;30(5):620-628.
- doi: 10.3904/kjim.2015.30.5.620
BACKGROUND/AIMS: Newer P2Y12 inhibitors, such as prasugrel and ticagrelor, have greater antiplatelet efficacy but may increase the risk of bleeding. In this study, we compared the pharmacodynamic efficacy of prasugrel... -
- CITED
-
- Close
- SHARE
-
- Close
- Dual antiplatelet therapy and non-cardiac surgery: evolving issues and anesthetic implications
-
Song JW, Soh S, Shim JK
- KMID: 2402889
- Korean J Anesthesiol.
- 2017 Feb;70(1):13-21.
- doi: 10.4097/kjae.2017.70.1.13
Dual antiplatelet therapy (DAPT) consisting of aspirin plus a P2Yâ‚â‚‚ inhibitor (clopidogrel, prasugrel, or ticagrelor) is imperative for the treatment of acute coronary syndrome, particularly during the re-endothelialization period after... -
- CITED
-
- Close
- SHARE
-
- Close
- A Comparative Study the USA, Europe and Korea Guidelines of Antiplatelet Therapy for Patients with Acute Coronary Syndrome
-
Jung EJ, Lee CW, Baek IH
- KMID: 2226412
- Korean J Clin Pharm.
- 2015 Sep;25(3):200-208.
- doi: 10.0000/kjcp.2015.25.3.200
OBJECTIVE: Patients with acute coronary syndrome (ACS) are typically managed with dual antiplatelet therapy of acetylsalicylic acid (aspirin) and P2Y12 receptor inhibitor. In this study, we discussed current and previous... -
- CITED
-
- Close
- SHARE
-
- Close
- The Use Pattern and Clinical Impact of New Antiplatelet Agents Including Prasugrel and Ticagrelor on 30-day Outcomes after Acute Myocardial Infarction in Korea: Korean Health Insurance Review and Assessment Data
-
Kim C, Shin DH, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Hong MK, Park J, Lee H, Choi YJ, Choi YS, Oh SK, Jang Y
- KMID: 2396482
- Korean Circ J.
- 2017 Nov;47(6):888-897.
- doi: 10.4070/kcj.2017.0072
BACKGROUND AND OBJECTIVES: Despite the favorable efficacy of new antiplatelet agents demonstrated in randomized controlled trials, their clinical implications in Korea are unclear. The purpose of this study was to... -
- CITED
-
- Close
- SHARE
-
- Close
- Simultaneous Multivessel Acute Stent Thrombosis in a Patient with Gastrointestinal Bleeding
-
Kim JY, Kim HI, Kim JW, Kim JH, Kim YN, Song YB, Kim JS
- KMID: 2268845
- Korean J Med.
- 2016 Apr;90(4):322-325.
- doi: 10.3904/kjm.2016.90.4.322
Stent thrombosis is a rare, but potentially catastrophic complication of stent implantation. Dual antiplatelet therapy with aspirin and a thienopyridine (clopidogrel, prasugrel, or ticagrelor) is essential to minimize the risk... -
- CITED
-
- Close
- SHARE
-
- Close
